Cardinal Health to acquire heart-product business

Cardinal Health has agreed to purchase Johnson & Johnson’s heart-product business, Cordis, according to a news article.

Advertisement

Cardinal Health will put up a cool $1.49 billion to purchase Cordis from Johnson & Johnson. Cordis focuses on creating medical devices, specifically stents and catheters.

With the addition of Cordis, Cardinal Health increases its inventory of products for sale to hospitals, ASCs and physicians.

Don Casey, head of Cardinal’s medical segment stated,”As we bring more of these strategies to bear, that’s going to make us increasingly important to hospitals.

The deal is expected to close close to the end of the year.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.